BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6778293)

  • 21. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The macromolecular structure of the first component of complement.
    Assimeh SN; Painter RH
    J Immunol; 1975 Aug; 115(2):488-94. PubMed ID: 807640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformational changes of the subunits C1q, C1r and C1s of human complement component C1 demonstrated by 125I labeling.
    Bauer J; Valet G
    Biochim Biophys Acta; 1981 Aug; 670(1):129-33. PubMed ID: 6268178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the first component of human complement (C1) by antibody-antigen aggregates.
    Dodds AW; Sim RB; Porter RR; Kerr MA
    Biochem J; 1978 Nov; 175(2):383-90. PubMed ID: 743203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical characterization and location of ionic interactions involved in the assembly of the C1 complex of human complement.
    Illy C; Thielens NM; Arlaud GJ
    J Protein Chem; 1993 Dec; 12(6):771-81. PubMed ID: 8136028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement components and activation in primary biliary cirrhosis.
    Lindgren S; Laurell AB; Eriksson S
    Hepatology; 1984; 4(1):9-14. PubMed ID: 6420306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classical complement pathway components C1r and C1s: purification from human serum and in recombinant form and functional characterization.
    Rossi V; Bally I; Lacroix M; Arlaud GJ; Thielens NM
    Methods Mol Biol; 2014; 1100():43-60. PubMed ID: 24218249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pneumococcal antibodies and complement during and after periods of recurrent otitis.
    Prellner K; Kalm O; Pedersen FK
    Int J Pediatr Otorhinolaryngol; 1984 Mar; 7(1):39-49. PubMed ID: 6724809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation.
    Waldo FB; West CD
    Clin Immunol Immunopathol; 1987 Feb; 42(2):239-49. PubMed ID: 3026704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demonstration and quantitation of activation of the first component of complement in human serum.
    Ziccardi RJ; Cooper NR
    J Exp Med; 1978 Feb; 147(2):385-95. PubMed ID: 75238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trimer and tetramer complexes containing C1 esterase inhibitor, C1r and C1s, in serum and synovial fluid of patients with rheumatic disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol Methods; 1990 May; 129(1):55-61. PubMed ID: 2338498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19.
    Thiel S; Petersen SV; Vorup-Jensen T; Matsushita M; Fujita T; Stover CM; Schwaeble WJ; Jensenius JC
    J Immunol; 2000 Jul; 165(2):878-87. PubMed ID: 10878362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes.
    Sim RB; Arlaud GJ; Colomb MG
    Biochem J; 1979 Jun; 179(3):449-57. PubMed ID: 475762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement components, C1 activation and disease activity in SLE.
    Sturfelt G; Sjöholm AG; Svensson B
    Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
    Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
    Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FN-C1q and C1 INH C1r-C1s complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia.
    Hidvégi T; Ermolin GA; Efremov EE; Dikov MM; Kurmanova LV; Vnashenkova GV; Merkulova MV; Kókai M; Panya A; Füst G
    Immunol Lett; 1989 Jul; 22(1):1-6. PubMed ID: 2550362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C1R levels in normal human sera determined by electroimmunoassay.
    Sjöholm AG; Mårtensson U; Laurell AB
    Acta Pathol Microbiol Scand C; 1976 Oct; 84C(5):425-7. PubMed ID: 998269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E; Sorvillo J; Gigli I
    J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NH2-terminal calcium-binding domain of human complement C1s- mediates the interaction of C1r- with C1q.
    Busby TF; Ingham KC
    Biochemistry; 1990 May; 29(19):4613-8. PubMed ID: 2372546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement activation by pneumococci associated with acute otitis media.
    Prellner K
    Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):213-6. PubMed ID: 39420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.